首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5065篇
  免费   564篇
  国内免费   7篇
耳鼻咽喉   19篇
儿科学   136篇
妇产科学   79篇
基础医学   368篇
口腔科学   138篇
临床医学   370篇
内科学   763篇
皮肤病学   37篇
神经病学   145篇
特种医学   220篇
外科学   354篇
综合类   101篇
一般理论   1篇
预防医学   2130篇
眼科学   52篇
药学   527篇
肿瘤学   196篇
  2023年   39篇
  2022年   64篇
  2021年   57篇
  2020年   112篇
  2019年   66篇
  2018年   127篇
  2017年   122篇
  2016年   125篇
  2015年   142篇
  2014年   134篇
  2013年   226篇
  2012年   126篇
  2011年   129篇
  2010年   158篇
  2009年   185篇
  2008年   144篇
  2007年   152篇
  2006年   164篇
  2005年   177篇
  2004年   182篇
  2003年   168篇
  2002年   210篇
  2001年   198篇
  2000年   166篇
  1999年   235篇
  1998年   179篇
  1997年   224篇
  1996年   227篇
  1995年   152篇
  1994年   82篇
  1993年   144篇
  1992年   59篇
  1991年   68篇
  1990年   58篇
  1989年   78篇
  1988年   90篇
  1987年   91篇
  1986年   71篇
  1985年   66篇
  1984年   33篇
  1983年   41篇
  1982年   26篇
  1981年   27篇
  1980年   26篇
  1979年   31篇
  1976年   29篇
  1975年   19篇
  1974年   20篇
  1971年   22篇
  1970年   24篇
排序方式: 共有5636条查询结果,搜索用时 0 毫秒
101.
Impaired nutrition status is recognized as a risk factor for worse clinical outcomes in patients with chronic obstructive pulmonary disease (COPD). The aims of this study were to investigate how undernutrition is diagnosed, its prevalence, and whether there is an association between this condition and clinical outcomes in patients with COPD. The search for this systematic review of observational studies (PROSPERO: CRD42020191888) was performed in the PubMed, Embase, and Scopus databases, with no date or language restrictions. The studies had to report data on the diagnosis of undernutrition and its association with mortality, exacerbation, length of hospital stay, or quality of life in adult patients with COPD. A meta-analysis with a random-effects model was performed to combine data. Forty-nine studies were included (20 of them classified as having a low risk of bias), and the most common diagnostic method of undernutrition was body mass index (BMI) (n = 36). The pooled prevalence of undernutrition was equal to 20% (95% CI, 0.15–0.25; I² = 100%), and it was associated with mortality (risk ratio = 1.97; 95% CI, 1.55–2.50; I² = 98%), exacerbation (risk ratio = 1.73; 95% CI, 1.03–2.91; I² = 96%), and poorer quality of life (mean difference = 8.25; 95% CI, 5.40–11.10; I² = 79%). For all outcomes, the certainty of evidence was very low. In conclusion, undernutrition is prevalent and is associated with poorer outcomes in patients with COPD. However, undernutrition is mainly diagnosed by BMI, which underreports its prevalence, and the certainty of the evidence is very low.  相似文献   
102.
103.
104.
105.
106.
107.
108.
  1. 15-Lipoxygenase (15-LO) has been implicated in the pathogenesis of atherosclerosis because of its localization in lesions and the many biological activities exhibited by its products. To provide further evidence for a role of 15-LO, the effects of PD 146176 on the development of atherosclerosis in cholesterol-fed rabbits were assessed. This novel drug is a specific inhibitor of the enzyme in vitro and lacks significant non specific antioxidant properties.
  2. PD 146176 inhibited rabbit reticulocyte 15-LO through a mixed noncompetitive mode with a Ki of 197 nM. The drug had minimal effects on either copper or 2,2′-azobis(2-amidinopropane)hydrochloride (ABAP) induced oxidation of LDL except at concentrations 2 orders higher than the Ki.
  3. Control New Zealand rabbits were fed a high-fat diet containing 0.25% wt./wt. cholesterol; treated animals received inhibitor in this diet (175 mg kg−1, b.i.d.). Plasma concentrations of inhibitor were similar to the estimated Ki (197 nM). During the 12 week study, there were no significant differences in weight gain, haematocrit, plasma total cholesterol concentrations, or distribution of lipoprotein cholesterol.
  4. The drug plasma concentrations achieved in vivo did not inhibit low-density lipoprotein (LDL) oxidation in vitro. Furthermore, LDL isolated from PD 146176-treated animals was as susceptible as that from controls to oxidation ex vivo by either copper or ABAP.
  5. PD 146176 was very effective in suppressing atherogenesis, especially in the aortic arch where lesion coverage diminished from 15±4 to 0% (P<0.02); esterified cholesterol content was reduced from 2.1±0.7 to 0 μg mg−1 (P<0.02) in this region. Immunostainable lipid-laden macrophages present in aortic intima of control animals were totally absent in the drug-treated group.
  6. Results of these studies are consistent with a role for 15-LO in atherogenesis.
  相似文献   
109.
Dyer C 《The Health service journal》1997,107(5580):suppl 1, 3-suppl 1, 4
  相似文献   
110.
Honeybees and some other insects, in learning the sun's course, behave as if they can estimate the sun's position at times of day when they have never seen it, but there are competing ideas about the computational mechanisms underlying this ability. In an approach to this problem, we provided incubator-reared bees with opportunities to fly and see the sun only during the late afternoon. Then, on a cloudy day, we allowed bees to fly for the first time during the morning and early afternoon, and we observed how they oriented their waggle dances to indicate their direction of flight relative to the sun's position. The clouds denied the bees a direct view of celestial orientation cues and thus forced them to estimate the sun's position on the basis of their experience on previous evenings. During the test days, experience-restricted bees behaved during the entire morning as if they expected the sun to be in an approximately stationary position about 180 degrees from the average solar azimuth that they had experienced on previous evenings; then from about local noon onward they used the evening azimuth. This pattern suggests that honeybees are innately informed of the general pattern of solar movement, such that they can generate an internal representation that incorporates spatial and temporal features of the sun's course that they have never directly seen.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号